Scientists say the COVID-19 vaccines being developed in Russia and China share a potential shortcoming: They are based on a common cold virus that many people have been exposed to, potentially limiting their effectiveness.
Subscribe:
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on:
Follow Reuters on Facebook:
Follow Reuters on Twitter:
Follow Reuters on Instagram:
